Streetbeat News

Stock Prices

RMD

ResMed (NYSE:RMD) has significantly outperformed the market over the past 20 years, delivering an average annual return of 14.82%. A $1000 investment in RMD 20 years ago would be worth $15,784.26 today. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

July 26, 2024 | 4:00 pm

NEE

NextEra Energy (NYSE:NEE) has significantly outperformed the market over the past 20 years, delivering an average annual return of 11.46%. A $100 investment in NEE 20 years ago would be worth $874.86 today. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

July 26, 2024 | 4:00 pm

SSNC

SS&C Technologies Holdings (NASDAQ:SSNC) has received mixed analyst ratings over the past quarter, with a general trend towards bullish sentiment. Analysts have raised their price targets, reflecting an average target of $75.25, up from $69.50. The company's financials show strong revenue growth and net margins, but challenges in ROE and ROA.

Portfolio Pulse from Benzinga Insights

July 26, 2024 | 4:00 pm

DXCM

DexCom Inc (NASDAQ:DXCM) reported strong Q2 sales and EPS but lowered its 2024 sales guidance, leading to a stock decline. Despite short-term challenges, analysts remain optimistic about long-term growth prospects due to market expansion and product portfolio.

Portfolio Pulse from Vandana Singh

July 26, 2024 | 3:59 pm

CVM

CEL-SCI shares experienced a trading halt due to a circuit breaker triggered by a sharp decline. Despite this, the stock rebounded and is now up by 21.9%.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 3:59 pm

FBIN

Fortune Brands Innovations shares are trading higher following Q2 earnings. Multiple analysts raised their price targets following the report.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 3:54 pm

CVM

CEL-SCI Corporation has announced a best-efforts offering of 10.845 million shares and pre-funded warrants at $1.00 each, aiming to raise $10.845 million. The offering is expected to close on July 29, 2024.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 3:52 pm

AMWD

CCS

DFH

DHI

GRBK

IBP

ITB

JELD

MHK

MHO

TPH

Homebuilder stocks surged to record highs driven by expectations of interest rate cuts in September, despite struggling housing sales. The iShares U.S. Home Construction ETF (ITB) jumped 3.8%, and Bank of America upgraded Mohawk Industries (MHK) following strong Q2 earnings.

Portfolio Pulse from Piero Cingari

July 26, 2024 | 3:51 pm

AMD

AVGO

INTC

NVDA

QCOM

QQQ

VOO

AI chip stocks including Nvidia, AMD, Broadcom, and Qualcomm are rebounding after a selloff due to geopolitical tensions and poor Big Tech earnings. Nvidia supplier SK Hynix reported record profits, and China’s subsidies for new energy vehicles and consumer electronics are providing additional support. Analyst Christopher Rolland maintained a Positive rating on AMD with a $200 price target, citing potential gains in server CPU revenue and enterprise adoption. Investors can also gain exposure through ETFs like Vanguard S&P 500 ETF and Invesco QQQ Trust.

Portfolio Pulse from Anusuya Lahiri

July 26, 2024 | 3:49 pm

ALPMY

MRK

Astellas Pharma has received a positive opinion from the CHMP for the approval of PADCEV in combination with KEYTRUDA for the first-line treatment of advanced bladder cancer. This combination could become the first alternative to platinum-containing chemotherapy, showing nearly double the median overall survival in clinical trials.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 3:47 pm